Correlation Between Vaccinex and Fulcrum Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vaccinex and Fulcrum Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vaccinex and Fulcrum Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vaccinex and Fulcrum Therapeutics, you can compare the effects of market volatilities on Vaccinex and Fulcrum Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vaccinex with a short position of Fulcrum Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vaccinex and Fulcrum Therapeutics.

Diversification Opportunities for Vaccinex and Fulcrum Therapeutics

0.64
  Correlation Coefficient

Poor diversification

The 3 months correlation between Vaccinex and Fulcrum is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Vaccinex and Fulcrum Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fulcrum Therapeutics and Vaccinex is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vaccinex are associated (or correlated) with Fulcrum Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fulcrum Therapeutics has no effect on the direction of Vaccinex i.e., Vaccinex and Fulcrum Therapeutics go up and down completely randomly.

Pair Corralation between Vaccinex and Fulcrum Therapeutics

Given the investment horizon of 90 days Vaccinex is expected to generate 46.08 times less return on investment than Fulcrum Therapeutics. In addition to that, Vaccinex is 1.95 times more volatile than Fulcrum Therapeutics. It trades about 0.0 of its total potential returns per unit of risk. Fulcrum Therapeutics is currently generating about 0.22 per unit of volatility. If you would invest  324.00  in Fulcrum Therapeutics on August 31, 2024 and sell it today you would earn a total of  71.00  from holding Fulcrum Therapeutics or generate 21.91% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Vaccinex  vs.  Fulcrum Therapeutics

 Performance 
       Timeline  
Vaccinex 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vaccinex has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Fulcrum Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Fulcrum Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's essential indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Vaccinex and Fulcrum Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vaccinex and Fulcrum Therapeutics

The main advantage of trading using opposite Vaccinex and Fulcrum Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vaccinex position performs unexpectedly, Fulcrum Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fulcrum Therapeutics will offset losses from the drop in Fulcrum Therapeutics' long position.
The idea behind Vaccinex and Fulcrum Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Complementary Tools

Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Bonds Directory
Find actively traded corporate debentures issued by US companies
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Global Correlations
Find global opportunities by holding instruments from different markets